Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
USA v. Babich et al
Case Number:
1:16-cr-10343
Court:
Nature of Suit:
Judge:
Firms
- Brown Rudnick
- Clark Hill
- Donnelly Conroy
- Fick & Marx
- Fitch Law Partners
- Hogan Lovells
- King & Spalding
- Kobre & Kim
- Miner Siddall
- Mitchell Stein Carey
- Morgan Lewis
- Nixon Peabody
- Ropes & Gray
- Weil Gotshal
- White & Case
- Wilkinson Stekloff
Companies
Sectors & Industries:
-
May 02, 2019
Ex-Insys Execs Found Guilty In RICO Opioid Bribe Scheme
After weeks of near-silence, a Boston jury delivered a strong statement by convicting wealthy Insys Therapeutics Inc. founder John Kapoor and four other executives Thursday in a closely watched racketeering trial, during which prosecutors accused the Insys higher-ups of a scheme to bribe doctors to prescribe a powerful opioid.
-
May 01, 2019
Insys Jury Question Could Indicate Conviction On The Way
After more than three weeks of silence, a Boston federal jury asked a question Wednesday that may suggest it is leaning toward convicting at least one of the five former Insys Therapeutics Inc. executives charged with conspiring to bribe doctors to prescribe opioids to patients who didn't need them.
-
April 26, 2019
Feds Likely To Try Again If Insys Jury Deadlocks
For weeks, and without sending a single question or note to the court, a Boston federal jury has been mulling charges against former Insys Therapeutics executives charged with conspiring to bribe doctors to prescribe opioids, but if there's a deadlock, prosecutors are expected to keep pursuing the landmark case, experts say.
-
April 24, 2019
After 10 Days Of Jury Silence, Insys Exec Asks To Go Home
One of the five former Insys Therapeutics Inc. executives on trial for conspiring to bribe doctors to prescribe an opioid spray to patients who did not need it is asking the court to let her await her verdict from home as the jury enters its 11th day of deliberation.
-
April 05, 2019
'Massive Scheme' Or 'Big Lie'? Insys Execs In Jury's Hands
The fate of five former Insys Therapeutics Inc. executives charged with conspiring to bribe doctors to prescribe an opioid spray will be in the hands of a Boston jury after prosecutors argued Friday there is "overwhelming evidence" of the "massive scheme," and defense lawyers panned the case as "the big lie."
-
April 04, 2019
Insys Execs Put 'Profits Over Patients,' Feds Tell Jury
As a 10-week racketeering conspiracy trial reached closing arguments Thursday, federal prosecutors sought to convince a Boston jury that former executives at Insys Therapeutics exploited vulnerable patients by bribing doctors to prescribe the company's addictive fentanyl spray.
-
April 03, 2019
Insys Judge Says Part Of Gov't Racketeering Case Is 'Thin'
Part of the government's racketeering conspiracy case against five former Insys Therapeutics executives is "pretty darn thin," a Boston federal judge told attorneys Wednesday as testimony concluded in the 10-week trial.
-
April 02, 2019
Insys Judge Unmoved So Far By Midnight Acquittal Bid
The racketeering case against a group of top Insys Therapeutics Inc. brass appears headed for a jury next week after the presiding judge said Tuesday she still leans toward sending it that way despite a midnight acquittal motion — which spilled into an impromptu court battle — claiming federal prosecutors didn't make their case.
-
April 01, 2019
Insys Drug Was 'Amazing' For Pain, Patient Tells Jury
The fentanyl spray sold by Insys Therapeutics helped soothe excruciating pain in the aftermath of a car crash and multiple surgeries, a New Jersey man told a Boston federal jury Monday as the first defense witness in the racketeering conspiracy trial of five former Insys executives.
-
March 29, 2019
8 Insys Docs Tallied $28M In Medicare Costs, Jury Hears
Eight top prescribers of Insys Therapeutics Inc.'s opioid spray accounted for more than $28 million in Medicare bills for the drug, an FBI witness testified Friday as federal prosecutors tried to show the doctors doled out prescriptions in exchange for lucrative speaking engagements.